HLS Therapeutics Inc (OTCPK:HLTRF)
$ 2.73 0.19 (7.48%) Market Cap: 83.68 Mil Enterprise Value: 134.75 Mil PE Ratio: 0 PB Ratio: 1.02 GF Score: 58/100

HLS Therapeutics Inc at Jefferies Healthcare Conference (Virtual) Transcript

Jun 03, 2020 / 01:00PM GMT
Release Date Price: $15.22
Lily Pillari
Jefferies LLC - Analyst

My name is Lily Pillari and I am an analyst in the Jefferies healthcare investment banking department. It is my pleasure to introduce Greg Gubitz, CEO at HLS Therapeutics, to present at the Jefferies virtual healthcare conference. (Operator Instructions).

Greg Gubitz
HLS Therapeutics Inc. - CEO

Thank you. Good morning, everyone, and thank you, Lily, for the introduction. I am Greg Gubitz. I am the CEO and cofounder of HLS. And before I get going I really just wanted to thank Jefferies for this opportunity and to complement them on being able to pivot and to run this on a virtual basis. It's quite an undertaking and I'm hoping it all runs very smoothly today.

(Operator Instructions). They are running on a very tight timeline this morning. And if we don't get an opportunity to answer all your questions, please feel free to reach out to either me directly after the call or with your Jefferies banker, and we'd be more than happy to have any follow-up discussions that you feel are appropriate.

So, let me

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot